|
| | | | | | | | | | | | | | | | | |
| | | Fair Value Measurements at Reporting Date Using | | |
| As of March 31, 2015 | | Quoted Prices in Active Markets for Identical Financial Instruments | | Significant Other Observable Inputs | | Significant Unobservable Inputs | | |
| (Level 1) | | (Level 2) | | (Level 3) | | Balance Sheet Classification |
Assets | | | | | | | | | |
Bank and time deposits | $ | 175 |
| | $ | 175 |
| | $ | — |
| | $ | — |
| | Cash equivalents |
Money market funds | 7 |
| | 7 |
| | — |
| | — |
| | Cash equivalents |
Available-for-sale securities: | | | | | | | | | |
Corporate bonds | 468 |
| | — |
| | 468 |
| | — |
| | Short-term investments and cash equivalents |
U.S. Treasury securities | 214 |
| | 214 |
| | — |
| | — |
| | Short-term investments |
U.S. agency securities | 180 |
| | — |
| | 180 |
| | — |
| | Short-term investments and cash equivalents |
Commercial paper | 140 |
| | | | 140 |
| | | | Short-term investments and cash equivalents |
Foreign currency derivatives | 18 |
| | — |
| | 18 |
| | — |
| | Other current assets |
Deferred compensation plan assets (a) | 9 |
| | 9 |
| | — |
| | — |
| | Other assets |
Total assets at fair value | $ | 1,211 |
| | $ | 405 |
| | $ | 806 |
| | $ | — |
| | |
Liabilities | | | | | | | | | |
Contingent consideration (b) | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | Accrued and other current liabilities |
Foreign currency derivatives | 9 |
| | — |
| | 9 |
| | — |
| | Accrued and other current liabilities |
Deferred compensation plan liabilities (a) | 9 |
| | 9 |
| | — |
| | — |
| | Other liabilities |
Total liabilities at fair value | $ | 18 |
| | $ | 9 |
| | $ | 9 |
| | $ | — |
| | |